Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,040,782
  • Shares Outstanding, K 31,889
  • Annual Sales, $ 1,534 M
  • Annual Income, $ 30,300 K
  • 36-Month Beta 1.43
  • Price/Sales 2.66
  • Price/Cash Flow 45.85
  • Price/Book 9.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.85
  • Number of Estimates 7
  • High Estimate 0.89
  • Low Estimate 0.82
  • Prior Year 0.56
  • Growth Rate Est. (year over year) +51.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
124.79 +3.25%
on 01/23/19
139.80 -7.84%
on 02/05/19
+4.10 (+3.29%)
since 01/22/19
3-Month
103.76 +24.17%
on 12/24/18
140.91 -8.57%
on 12/04/18
+9.02 (+7.53%)
since 11/21/18
52-Week
55.49 +132.19%
on 03/01/18
140.91 -8.57%
on 12/04/18
+71.82 (+125.96%)
since 02/22/18

Most Recent Stories

More News
Quest Diagnostics Grows on Innovation Amid Reimbursement Woe

Quest Diagnostics' (DGX) progress in prescription drug monitoring, QuantiFERON and non-invasive prenatal screening are part of its recent major developments.

ABT : 76.13 (+1.32%)
DGX : 87.80 (-0.01%)
AMED : 128.84 (+1.68%)
PEN : 146.34 (+0.01%)
Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

MMSI : 59.60 (-0.57%)
AMED : 128.84 (+1.68%)
PNW : 93.22 (+1.36%)
RCL : 120.93 (-0.03%)
LUV : 53.62 (-1.27%)
Have Faith in DuPont Analysis & Pick 5 Quality Stocks

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

RHI : 68.26 (+1.29%)
FIX : 54.44 (+4.79%)
AMED : 128.84 (+1.68%)
FL : 59.64 (-0.62%)
CASY : 134.86 (+0.79%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

XLV : 92.55 (+0.92%)
VHT : 173.98 (+0.95%)
LHCG : 111.00 (+0.84%)
AMED : 128.84 (+1.68%)
NEOG : 62.94 (+2.46%)
PSCH : 122.87 (+0.57%)
Worried About Rate Hikes? Buy These 5 Low Leverage Stocks

If a company is highly leveraged, investors will not add it to their portfolios. A high degree of financial leverage means high interest payments, which may affect a company's bottom line.

MMSI : 59.60 (-0.57%)
AMED : 128.84 (+1.68%)
PNW : 93.22 (+1.36%)
RCL : 120.93 (-0.03%)
LUV : 53.62 (-1.27%)
Investor Expectations to Drive Momentum within International Business Machines, Trex, ForeScout Technologies, Red Hat, Amedisys, and Atrion -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of International Business Machines...

ATRI : 798.79 (+0.60%)
IBM : 139.25 (+1.02%)
AMED : 128.84 (+1.68%)
TREX : 75.73 (+0.12%)
FSCT : 39.07 (+0.75%)
RHT : 182.83 (-0.04%)
Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings?

An increased reimbursement of approximately $1 million has boosted Amedisys' (AMED) Hospice business.

ACIU : 4.35 (-6.05%)
APTO : 1.99 (+3.11%)
AMED : 128.84 (+1.68%)
ADRO : 4.09 (+0.25%)
Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose

The favorable PRODIGY study result by Medtronic (MDT) is undoubtedly a timely, strategic finding.

ABT : 76.13 (+1.32%)
AMED : 128.84 (+1.68%)
PEN : 146.34 (+0.01%)
MDT : 93.77 (+1.25%)
Align Technology Unveils iTero Element 5D Imaging System

Align Technology (ALGN) continues to expand work flow options of iTero scanners.

ABT : 76.13 (+1.32%)
AMED : 128.84 (+1.68%)
PEN : 146.34 (+0.01%)
ALGN : 253.99 (+1.50%)
Amedisys Announces Retirement of Board Member Linda J. Hall

Amedisys, Inc. (NASDAQ: AMED), America's leading independent home health, hospice and personal care company, announced today that Ms. Linda J. Hall, Ph.D., will retire from its Board of Directors. After...

AMED : 128.84 (+1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade AMED with:

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 132.33
1st Resistance Point 130.59
Last Price 128.84
1st Support Level 126.37
2nd Support Level 123.89

See More

52-Week High 140.91
Last Price 128.84
Fibonacci 61.8% 108.28
Fibonacci 50% 98.20
Fibonacci 38.2% 88.12
52-Week Low 55.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar